Archives
Calpain Inhibitor I, ALLN: Lab Guide
2026-09-17
Calpain Inhibitor I, ALLN (SKU A2602) is a water-insoluble cysteine-protease inhibitor used to investigate calpain- and cathepsin-associated proteolysis in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. This guide focuses on stock preparation, controls, and interpretation; the reagent is for research use only and is not a diagnostic or therapeutic product.
DiscoveryProbe Protease Inhibitor Library: HTS Guide
2026-09-16
The 825-compound DiscoveryProbe Protease Inhibitor Library supports a practical progression from biochemical protease inhibition to cell-based mechanism mapping. Its pre-dissolved, automation-ready format helps researchers compare protease activity modulation, apoptosis phenotypes, and disease-relevant responses while reducing compound-handling variability.
From USP42 Biology to Precision Biotin Detection
2026-09-16
Translational oncology requires more than a compelling mechanism: it requires readouts that connect pathway perturbation with reproducible cellular and tissue evidence. This article examines how Streptavidin – Cy5 can support the validation of USP42–JNK/p38 biology while defining practical controls, competitive tradeoffs, and the boundaries between preclinical research and clinical translation.
DiscoveryProbe Protease Inhibitor Library Workflow
2026-09-15
Build reproducible biochemical, apoptosis, cancer, and infectious-disease screens around 825 pre-dissolved protease inhibitors. The workflow combines automation-ready compound handling with orthogonal validation so screening hits become interpretable mechanistic leads rather than isolated assay signals.
SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis
2026-09-15
The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced renal fibrosis and inflammation. Using AZ505 or LLY507 in kidney injury models, the authors connect SMYD2 inhibition with reduced epithelial–mesenchymal transition, extracellular matrix remodeling, inflammatory cytokines, and Smad3/STAT3 signaling, while highlighting important limits for translation beyond the experimental setting.
DiscoveryProbe Immunology/Inflammation Library
2026-09-14
The DiscoveryProbe Immunology/Inflammation Compound Library is a curated 295-compound collection for immunomodulator screening, inflammation target validation, and immune pathway profiling. L1042 combines diverse small molecules with pre-dissolved 10 mM DMSO formatting and a workflow-compatible set of inflammatory and immune-related targets.
Neomycin sulfate: Reliable Assay Workflows
2026-09-14
A scenario-driven guide to using Neomycin sulfate (SKU B1795) in cell-based viability, proliferation, and mechanistic assays. It addresses solvent compatibility, controls, concentration–time optimization, interpretation of antibiotic-associated phenotypes, and practical criteria for selecting a reliable research-grade supplier.
Dinaciclib (SCH727965): Cell-Cycle Workflows
2026-09-13
Use Dinaciclib (SCH727965) to connect CDK-driven cell-cycle control with apoptosis, Rb signaling, and tissue-boundary behavior. This workflow-focused guide combines oncology assays with quantitative imaging strategies inspired by Drosophila morphogenesis research.
WAY-100635 for Pain Circuit Pharmacology
2026-09-12
Use WAY-100635 as a selective 5-HT1A receptor challenge tool to separate serotonergic signaling from cannabinoid, inflammatory, sensory, and affective effects in pain models. This workflow connects receptor binding and functional assays with behavioral pharmacology while highlighting controls needed for translational interpretation.
SB525334 TGF-beta1 Receptor Inhibitor Guide
2026-09-11
A scenario-based guide to using SB525334 (TGF-beta1 receptor inhibitor), SKU A5602, to separate ALK5-dependent signaling from nonspecific cytotoxicity in viability, proliferation, renal, and fibrosis research. It covers assay design, solvent control, pathway readouts, interpretation, and practical product-selection criteria.
nor-NOHA Acetate Workflows for Cancer Research
2026-09-11
Use nor-NOHA acetate to build controlled arginase-inhibition experiments spanning HepG2 apoptosis, invasion biology, endothelial assays, and exploratory AML immunometabolism. This guide separates established findings from hypothesis-generating applications and emphasizes reversible dosing, orthogonal readouts, and practical troubleshooting.
0.4% Trypan Blue Solution: Practical Workflow
2026-09-10
0.4% Trypan Blue Solution supports membrane-integrity-based cell viability measurement and live/dead cell discrimination during research cell counting. It is intended for research workflows and cytotoxicity assay support, not diagnostic, medical, or clinical use, and it does not by itself resolve apoptosis from necrosis.
Standardized Whole-Blood Stimulation for Immunometabolism
2026-09-10
Zhao and colleagues describe a standardized fresh whole-blood stimulation protocol for measuring cytokine responses while experimentally modulating immune-cell metabolism. The workflow improves reproducibility and scalability for cohort studies and provides a practical framework for testing how metabolic pathways shape innate and adaptive immune function.
N2703 for Neuro-Cardiac Signaling Workflows
2026-09-09
Use N2703 as a controlled perturbation in neuron–adipocyte–cardiomyocyte assays to test how cellular signaling changes propagate toward electrical phenotypes. This workflow emphasizes concentration control, orthogonal validation, and troubleshooting rather than assigning an unproven target to the compound.
β-Elemene Inhibits 3T3-L1 Adipogenesis via AMPK
2026-09-09
The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis and a regulator of insulin-resistance phenotypes in differentiated 3T3-L1 cells. Its central contribution is linking reduced lipid accumulation and restored glucose consumption with recovery of AMPK signaling, while also defining a practical in vitro workflow for metabolic research.
756 records 8/51 page Previous Next First page 上5页 678910 下5页 Last page